(Q37633814)

English

Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer

scientific article published on 15 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Phase I trial of intravesical recombinant adenovirus mediated interferon-α2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

Colin P N Dinney

1

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Mark B Fisher

2

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Neema Navai

3

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Michael A O'Donnell

4

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

David Cutler

5

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Alice Abraham

6

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Sophia Young

7

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Beth Hutchins

8

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Maria Caceres

9

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Narendra Kishnani

10

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

George Sode

11

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Constance Cullen

12

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Guangcheng Zhang

13

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

H Barton Grossman

14

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Ashish M Kamat

15

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Marshall Gonzales

16

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Michael Kincaid

17

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Nancy Ainslie

18

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Daniel C Maneval

19

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Matthew F Wszolek

20

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

William F Benedict

21

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

language of work or name

0 references

publication date

15 March 2013

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Journal of Urology

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

190

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

850-856

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Conditioned medium from Ad-IFN-alpha-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

23 August 2017

Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

23 August 2017

Direct gene transfer of adenoviral-mediated interferon α into human bladder cancer cells but not the bystander factors produced induces endoplasmic reticulum stress-related cytotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

6 September 2017

Direct cytotoxicity produced by adenoviral-mediated interferon α gene transfer in interferon-resistant cancer cells involves ER stress and caspase 4 activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

14 September 2017

Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon alpha: possible use as a surrogate marker

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

14 September 2017

Efficacy of a single intravesical treatment with Ad-IFN/Syn 3 is dependent on dose and urine IFN concentration obtained: implications for clinical investigation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

14 September 2017

Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

14 September 2017

The treated natural history of high risk superficial bladder cancer: 15-year outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

25 June 2018

Sustained intravesical interferon protein exposure is achieved using an adenoviral-mediated gene delivery system: a study in rats evaluating dosing regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

1 September 2018

Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

1 September 2018

Role of tumor necrosis factor-related apoptosis-inducing ligand in interferon-induced apoptosis in human bladder cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

1 September 2018

Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

1 September 2018

Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

1 September 2018

Identification of polyamides that enhance adenovirus-mediated gene expression in the urothelium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

1 September 2018

Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

1 September 2018

Superficial bladder cancer: the role of interferon-alpha.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3951790

1 September 2018

Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23507396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23507396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/23507396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23507396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenoviral-mediated interferon α overcomes resistance to the interferon protein in various cancer types and has marked bystander effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/23507396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JURO.2013.03.030

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37633814&oldid=2153443929"